Marchex, Inc. (NASDAQ:MCHX – Get Free Report) was the target of a significant decrease in short interest during the month of April. As of April 15th, there was short interest totaling 19,026 shares, a decrease of 28.2% from the March 31st total of 26,512 shares. Currently, 0.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 8,563 shares, the short-interest ratio is presently 2.2 days.
Marchex Trading Down 0.6%
Marchex stock traded down $0.01 during midday trading on Friday, hitting $1.73. 3,077 shares of the stock were exchanged, compared to its average volume of 16,205. Marchex has a fifty-two week low of $1.26 and a fifty-two week high of $2.31. The stock has a market capitalization of $75.96 million, a price-to-earnings ratio of -14.42 and a beta of 1.96. The stock’s 50-day simple moving average is $1.54 and its 200 day simple moving average is $1.62.
Marchex (NASDAQ:MCHX – Get Free Report) last announced its earnings results on Wednesday, March 25th. The technology company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.03). The company had revenue of $10.85 million for the quarter, compared to analysts’ expectations of $10.97 million. Marchex had a negative return on equity of 15.14% and a negative net margin of 11.53%. Equities analysts anticipate that Marchex will post -0.03 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
View Our Latest Research Report on Marchex
Institutional Inflows and Outflows
Several hedge funds have recently bought and sold shares of the stock. XTX Topco Ltd purchased a new position in shares of Marchex in the fourth quarter valued at approximately $26,000. Jane Street Group LLC purchased a new position in shares of Marchex in the first quarter valued at approximately $30,000. Manatuck Hill Partners LLC purchased a new position in shares of Marchex in the second quarter valued at approximately $88,000. Marathon Capital Management boosted its stake in shares of Marchex by 13.9% in the third quarter. Marathon Capital Management now owns 61,500 shares of the technology company’s stock valued at $110,000 after purchasing an additional 7,500 shares during the period. Finally, Acuitas Investments LLC purchased a new position in shares of Marchex in the first quarter valued at approximately $207,000. Hedge funds and other institutional investors own 73.46% of the company’s stock.
Marchex Company Profile
Marchex, Inc (NASDAQ: MCHX) operates a call data and analytics platform designed to help businesses measure and optimize customer interactions. The company’s core services include call tracking, conversational analytics and performance marketing solutions that attribute phone calls to specific advertising campaigns. By capturing and analyzing voice interactions, Marchex enables advertisers, agencies and brands to gain actionable insights into caller intent, marketing ROI and customer behavior.
Through its suite of technologies, Marchex offers real-time call monitoring, keyword spotting and AI-driven transcription to surface trends and conversion signals from inbound calls.
Read More
Receive News & Ratings for Marchex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marchex and related companies with MarketBeat.com's FREE daily email newsletter.
